Literature DB >> 16736175

[Methylation and other new concepts for the origin of hepatocellular carcinoma].

A Tannapfel1.   

Abstract

Methylation takes place when a methyl group, comprised of a carbon and three hydrogen atoms (CH3), attaches to the individual DNA bases. This modification of the DNA leads to a change in gene expression. Changes in the methylation status of the DNA belong to the most common gene changes leading to malignant tumours. Recent studies have shown that three different mechanisms play a role in the effect of methylation: global hypomethylation, hypermethylation of individual gene segments and the deregulated expression of DNA methyltransferases. Such DNA methylation is also one of the most homogenous and consistent molecular changes in hepatocellular carcinoma (HCC). Moreover, the hypermethylation of specific genes has been shown to precede the development of malignant tumours. Thus, DNA methylation is a possible biomarker for the early discovery of HCC. The reversibility of methylation also offers a possible future treatment option.

Entities:  

Mesh:

Year:  2006        PMID: 16736175     DOI: 10.1007/s00292-006-0837-y

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  16 in total

1.  Methylation-specific polymerase chain reaction.

Authors:  Oliver Galm; James G Herman
Journal:  Methods Mol Med       Date:  2005

2.  Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men.

Authors:  Ming-Whei Yu; Shiou-Hwei Yeh; Pei-Jer Chen; Yun-Fan Liaw; Chih-Lin Lin; Chun-Jen Liu; Wei-Liang Shih; Jia-Horng Kao; Ding-Shinn Chen; Chien-Jen Chen
Journal:  J Natl Cancer Inst       Date:  2005-02-16       Impact factor: 13.506

Review 3.  DNA methylation and gene silencing in cancer.

Authors:  Stephen B Baylin
Journal:  Nat Clin Pract Oncol       Date:  2005-12

4.  Hepatitis B virus X protein represses E-cadherin expression via activation of DNA methyltransferase 1.

Authors:  Jung-Ok Lee; Hyun Jin Kwun; Jin Kyu Jung; Kyung Hee Choi; Do Sik Min; Kyung Lib Jang
Journal:  Oncogene       Date:  2005-10-06       Impact factor: 9.867

5.  Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers.

Authors:  Angelo Agathanggelou; Ashraf Dallol; Sabine Zöchbauer-Müller; Catherine Morrissey; Sofia Honorio; Luke Hesson; Tommy Martinsson; Kwun M Fong; Michael J Kuo; Po Wing Yuen; Eamonn R Maher; John D Minna; Farida Latif
Journal:  Oncogene       Date:  2003-03-13       Impact factor: 9.867

Review 6.  The altered DNA methylation pattern and its implications in liver cancer.

Authors:  Jing De Zhu
Journal:  Cell Res       Date:  2005-04       Impact factor: 25.617

7.  Proteolytic processing converts the repelling signal Sema3E into an inducer of invasive growth and lung metastasis.

Authors:  Claus Christensen; Noona Ambartsumian; Giorgio Gilestro; Birthe Thomsen; Paolo Comoglio; Luca Tamagnone; Per Guldberg; Eugene Lukanidin
Journal:  Cancer Res       Date:  2005-07-15       Impact factor: 12.701

8.  [Preneoplasia of the liver. Definition--differential diagnosis--clinical consequences].

Authors:  A Tannapfel; C Wittekind
Journal:  Pathologe       Date:  2001-11       Impact factor: 1.011

Review 9.  DNA methyltransferase inhibitors and the development of epigenetic cancer therapies.

Authors:  Frank Lyko; Robert Brown
Journal:  J Natl Cancer Inst       Date:  2005-10-19       Impact factor: 13.506

10.  Identification of novel proteins associated with hepatocellular carcinomas using protein microarrays.

Authors:  Andrea Tannapfel; Kathrin Anhalt; Philip Häusermann; Florian Sommerer; Markus Benicke; Dirk Uhlmann; Helmut Witzigmann; Johann Hauss; Christian Wittekind
Journal:  J Pathol       Date:  2003-10       Impact factor: 7.996

View more
  2 in total

1.  DNA methyltransferase 3B promoter polymorphism and its susceptibility to primary hepatocellular carcinoma in the Chinese Han nationality population: a case-control study.

Authors:  Ying Wu; Ju-Sheng Lin
Journal:  World J Gastroenterol       Date:  2007-12-07       Impact factor: 5.742

2.  Response of MiRNA-22-3p and MiRNA-149-5p to Folate Deficiency and the Differential Regulation of MTHFR Expression in Normal and Cancerous Human Hepatocytes.

Authors:  Chao Li; Juan Ni; Yao-Xian Liu; Han Wang; Zi-Qing Liang; Xu Wang
Journal:  PLoS One       Date:  2017-01-03       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.